These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32579399)

  • 1. Point-of-Care Drug of Abuse Testing in the Opioid Epidemic.
    Li Z; Wang P
    Arch Pathol Lab Med; 2020 Nov; 144(11):1325-1334. PubMed ID: 32579399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):132-9. PubMed ID: 22104462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solving the Opioid Crisis: Respiratory Depression by Opioids as Critical End Point.
    Montandon G; Slutsky AS
    Chest; 2019 Oct; 156(4):653-658. PubMed ID: 31194974
    [No Abstract]   [Full Text] [Related]  

  • 5. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The North American opioid epidemic: opportunities and challenges for clinical laboratories.
    Delaney SR; Tacker DH; Snozek CLH
    Crit Rev Clin Lab Sci; 2022 Aug; 59(5):309-331. PubMed ID: 35166639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Opioid Epidemic on Drug Testing.
    McMillin GA; Johnson-Davis KL; Kelly BN; Scott B; Yang YK
    Ther Drug Monit; 2021 Feb; 43(1):14-24. PubMed ID: 33230043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
    Atluri S; Sudarshan G; Manchikanti L
    Pain Physician; 2014; 17(2):E119-28. PubMed ID: 24658483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doing Our Part to Mitigate the Opioid Crisis.
    Fancher C; Terando AM
    Ann Surg Oncol; 2020 Mar; 27(3):625-626. PubMed ID: 31853759
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory testing for prescription opioids.
    Milone MC
    J Med Toxicol; 2012 Dec; 8(4):408-16. PubMed ID: 23180358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rural perspective on the opioid crisis.
    Knox R
    Nurs Manage; 2019 Aug; 50(8):6. PubMed ID: 31361689
    [No Abstract]   [Full Text] [Related]  

  • 12. Opioid prescription patterns in Germany and the global opioid epidemic: Systematic review of available evidence.
    Rosner B; Neicun J; Yang JC; Roman-Urrestarazu A
    PLoS One; 2019; 14(8):e0221153. PubMed ID: 31461466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of oral fluid in compliance monitoring of opioid medications.
    Conermann T; Gosalia AR; Kabazie AJ; Moore C; Miller K; Fetsch M; Irvan D
    Pain Physician; 2014; 17(1):63-70. PubMed ID: 24452646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids with abuse-deterrent properties: A regulatory and technological overview.
    Haddox JD
    J Opioid Manag; 2017; 13(6):397-413. PubMed ID: 29308587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems.
    Cobaugh DJ; Gainor C; Gaston CL; Kwong TC; Magnani B; McPherson ML; Painter JT; Krenzelok EP
    Am J Health Syst Pharm; 2014 Sep; 71(18):1539-54. PubMed ID: 25174015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fourth Amendment and random drug testing of people with chronic pain.
    Collen M
    J Pain Palliat Care Pharmacother; 2011; 25(1):42-8. PubMed ID: 21426217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioids.
    Brody H
    Nature; 2019 Sep; 573(7773):S1. PubMed ID: 31511676
    [No Abstract]   [Full Text] [Related]  

  • 18. The Benefits and Challenges of Point-of-Care Testing in Rural and Remote Primary Care Settings in Australia.
    Shephard M; Shephard A; Matthews S; Andrewartha K
    Arch Pathol Lab Med; 2020 Nov; 144(11):1372-1380. PubMed ID: 33106858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pill counts and pill rental: unintended entrepreneurial opportunities.
    Viscomi CM; Covington M; Christenson C
    Clin J Pain; 2013 Jul; 29(7):623-4. PubMed ID: 23328335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.
    Yang JC; Roman-Urrestarazu A; Brayne C
    PLoS One; 2020; 15(3):e0229787. PubMed ID: 32126120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.